Table 3 Cardioprotective medication prescription within 1 year of diabetes diagnosis, by sex and cardiovascular disease status
From: Sex-based disparities in cardioprotective medication use in adults with diabetes
< 55 YEARS | ||||||
|---|---|---|---|---|---|---|
|  | CVD (N = 1,493 ) | No CVD (n = 8,953) | ||||
| Â | Men | Women | p-value | Men | Women | p-value |
|  | N = 905 | N = 588 |  | N = 4,836 | N = 4,117 |  |
Statin | 366 (40.4) | 180 (30.6) | 0.0001 | 997 (20.6) | 596 (14.48) | <0.0001 |
ACEi | 431 (47.6) | 225 (38.3) | 0.0004 | 1,613 (33.4) | 1,071 (26.0) | <0.0001 |
ARB | 105 (11.6) | 78(13.3) | 0.338 | 410 (8.5) | 402 (9.8) | 0.035 |
ACEi or ARB | 511 (56.5) | 273 (46.4) | 0.0001 | 1,903 (39.4) | 1,382 (33.6) | <0.0001 |
At least one of the above | 605 (66.9) | 340 (57.8) | 0.0004 | 2281 (47.2) | 1608 (39.1) | <0.0001 |
55 YEARS + | ||||||
|  | CVD (N = 10,019) | No CVD (N = 12,829 ) | ||||
| Â | Men | Women | p-value | Men | Women | p-value |
|  | N = 5,599 | N = 4,420 |  | N = 6,834 | N = 5,995 |  |
Statin | 1,680 (30.0) | 1,142 (25.8) | <0.0001 | 1,325 (19.4) | 1,314 (21.9) | 0.0004 |
ACEi | 2,653 (47.4) | 1,931 (43.7) | 0.0002 | 2,406 (35.2) | 2,124 (35.4) | 0.8 |
ARB | 600 (10.7) | 709 (16.0) | <0.0001 | 760 (11.1) | 815 (13.6) | <0.0001 |
ACEi or ARB | 3,084 (55.1) | 2,458 (55.6) | 0.6 | 2,957 (43.3) | 2,759 (46.0) | 0.002 |
At least one of the above | 3545 (63.3) | 2800 (63.4) | 0.9 | 3415 (49.9) | 3263 (54.4) | <0.0001 |